首页> 外文学位 >Modifiable and nonmodifiable characteristics of sleep disturbance in oncology outpatients during chemotherapy.
【24h】

Modifiable and nonmodifiable characteristics of sleep disturbance in oncology outpatients during chemotherapy.

机译:肿瘤门诊化疗期间睡眠障碍的可更改和不可更改的特征。

获取原文
获取原文并翻译 | 示例

摘要

Study Objectives: In a sample of outpatients with breast, gastrointestinal (GI), gynecological (GYN), and lung cancer who received two cycles of chemotherapy (CTX) the purposes were to: evaluate for inter-individual differences in the severity of sleep disturbance and to determine which demographic, clinical, and symptom characteristics were associated with initial levels as well as the trajectories of sleep disturbance.;Methods: This study is part of a larger, longitudinal study of the symptom experience of oncology outpatients receiving CTX. A total of 1,331 patients completed study questionnaires in their homes, at six time points over two cycles of CTX (prior to CTX administration, approximately 1 week after CTX administration, and approximately 2 weeks after CTX administration). Questionnaires included demographic, clinical, and symptom assessments (i.e., General Sleep Disturbance Scale, Lee Fatigue Scale, Center for Epidemiological Studies-Depression Scale, Spielberger State-Trait Anxiety Inventories, Attentional Function Index).;Results: Hierarchical linear modeling based on full maximum likelihood estimation was performed. Characteristics associated with higher initial levels of sleep disturbance included: higher body mass index, poorer functional status, higher trait anxiety, higher depressive symptoms, and higher evening fatigue. Characteristics associated with the worse trajectories of sleep disturbance were higher levels of education and higher sleep disturbance. Characteristics associated with both higher initial levels and worse trajectories of sleep disturbance were higher morning fatigue and worse attentional function.;Conclusions: A great deal of inter-individual variability exists in sleep disturbance during CTX. The modifiable and non-modifiable characteristics found in this study can be used to identify higher risk patients and provide earlier interventions to reduce sleep disturbance.
机译:研究目标:在接受了两个化疗周期(CTX)的乳腺癌,胃肠道(GI),妇科(GYN)和肺癌门诊患者的样本中,目的是:评估睡眠障碍严重程度的个体差异并确定哪些人口统计学,临床和症状特征与初始水平以及睡眠障碍的轨迹有关。方法:本研究是对接受CTX的肿瘤科门诊患者症状经验进行的较大的纵向研究的一部分。总共1,331例患者在其家中完成了研究问卷,在两个CTX周期的六个时间点(CTX给药之前,CTX给药后约1周和CTX给药后约2周)。问卷包括人口统计学,临床和症状评估(即一般睡眠障碍量表,李疲劳量表,流行病学研究中心抑郁量表,Spielberger状态-特质焦虑量表,注意功能指数)。进行了最大似然估计。与较高的初始睡眠障碍水平相关的特征包括:更高的体重指数,更差的功能状态,更高的特质焦虑,更高的抑郁症状和更高的夜间疲劳。与睡眠障碍的恶化轨迹相关的特征是较高的教育水平和较高的睡眠障碍。与较高的初始水平和较差的睡眠障碍轨迹相关的特征是较高的早晨疲劳和较差的注意力功能。结论:CTX期间睡眠障碍存在很大的个体间差异。本研究中发现的可修改和不可修改的特征可用于识别高危患者,并提供早期干预措施以减少睡眠障碍。

著录项

  • 作者

    Mark, Sueann.;

  • 作者单位

    University of California, San Francisco.;

  • 授予单位 University of California, San Francisco.;
  • 学科 Oncology.;Nursing.
  • 学位 M.S.
  • 年度 2016
  • 页码 36 p.
  • 总页数 36
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号